DOCS vs WAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 11, 2026

DOCS

46.0
AI Score
VS
DOCS Wins

WAY

36.4
AI Score

Investment Advisor Scores

DOCS

46score
Recommendation
HOLD

WAY

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCS WAY Winner
Forward P/E 19.1571 14.4718 WAY
PEG Ratio 0.5895 0 Tie
Revenue Growth 7.3% 18.1% WAY
Earnings Growth -51.9% 16.7% WAY
Tradestie Score 46.0/100 36.4/100 DOCS
Profit Margin 25.5% 11.2% DOCS
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL DOCS

Relative Price Performance (Last 90 Days)

DOCS 1M: +23.9% · 3M: +30.6% WAY 1M: +15.9% · 3M: +32.8%

Current Technical Phase

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 58

RSI (14): 57.6 · Price: $25.33

WAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 60

RSI (14): 60.3 · Price: $25.01

Fundamentals Snapshot

Metric DOCS WAY
Market Cap
Forward P/E 15.6 13.3
Trailing P/E 30.5 35.5
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.9% 0.7%
Operating Margin 0.2% 0.2%
EPS 0.85 0.70
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DOCS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.